المؤلفون: Logtenberg SLM; Amsterdam UMC, Academic Medical Centre, Department of Obstetrics and Gynaecology, Amsterdam, The Netherlands; AVAG Amsterdam, Amsterdam, The Netherlands. Electronic address: s.l.m.logtenberg@gmail.com., Vink ML; Midwifery Practice Haarlemmermeer & Bollenstreek, Nieuw Vennep, The Netherlands., Godfried MB; Department of Anesthesiology, OLVG, Amsterdam, The Netherlands., Beenakkers ICM; Department of Anesthesiology, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Schellevis FG; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of General Practice & Elderly Care Medicine, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands; Netherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands., Mol BW; Department of Obstetrics and Gynaecology, Monash University Clayton, Clayton, Victoria, Australia., Verhoeven CJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Midwifery Science, AVAG, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands; Maxima Medical Centre, Veldhoven, The Netherlands.

المصدر: International journal of obstetric anesthesia [Int J Obstet Anesth] 2019 Aug; Vol. 39, pp. 22-28. Date of Electronic Publication: 2018 Nov 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9200430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3374 (Electronic) Linking ISSN: 0959289X NLM ISO Abbreviation: Int J Obstet Anesth Subsets: MEDLINE

مواضيع طبية MeSH: Analgesia, Obstetrical/*adverse effects , Analgesia, Patient-Controlled/*adverse effects , Analgesics, Opioid/*adverse effects , Remifentanil/*adverse effects, Female ; Humans ; Netherlands ; Pregnancy